02:30 PM EDT, 04/01/2024 (MT Newswires) -- AEON Biopharma ( AEON ) shares tumbled 40% in recent Monday trading after reporting a wider Q4 net loss last week.

The company reported Friday a diluted net loss of $0.71 per diluted share, compared with a loss of $0.25 a year earlier. One analyst polled by Capital IQ expected a loss of $0.40 normalized.

As expected, no revenue for the quarter ended Dec. 31 was reported.

The company said its cash, cash equivalents and investments, including the $15 million proceeds from a private placement, will be sufficient to fund its planned clinical studies and support corporate operations through June.

Additionally, the company said it will redeem all of its warrants to purchase its common shares, which were issued under a 2021 warrant agreement, at $0.10 each that are outstanding on April 29. The warrants were issued as part of the initial public offering.

Price: 6.96, Change: -4.64, Percent Change: -40.00